IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2 biotech developing an off-the-shelf immunotherapy for osteosarcoma.
Industry: Health Care
Latest Trade: ()
First Day Return:
Return from IPO:
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/31/2023 |
Offer Price | |
Price Range $5.00 - $5.00 | |
Offer Shares (mm) | 2.0 |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | |
Offer Price | |
Price Range $5.00 - $5.00 | |
Offer Shares (mm) | 2.0 |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Boustead Securities |
EF Hutton |
more |
Company Data | |
---|---|
Headquarters | Rockville, MD, United States |
Founded | 2018 |
Employees | 4 |
Website www.ostherapies.com |